Reducing mortality in severe sepsis with the implementation of a core 6-hour bundle: results from the Portuguese community-acquired sepsis study (SACiUCI study).
BACKGROUND
To evaluate the impact of compliance with a core version of the Surviving Sepsis Campaign 6-hour bundle on 28 days mortality.


METHODS
Cohort, multi-centre, prospective study on community-acquired sepsis (CAS).


RESULTS
Seventeen intensive care units (ICU) entered the study. Over a one year period, 4,142 patients were enrolled in the study. Of the 897 (24%) admitted with CAS, 778 (87%) had severe sepsis or septic shock on ICU admission. In the first six hours of hospital admission: (1) 62% had serum lactate measured; (2) 69% fluids administered; (3) 77% specimens collected for microbiology before antibiotic administration; (4) 48% blood cultures obtained; (5) 52% antibiotics administered within the first hour of the diagnosis; (6) vasopressors were given in 78%; (7) 56% had central venous measurement (CVP) measurement; (8) 17% had a central venous oxygen saturation (ScvO2) measurement; (9) dobutamine was administered in 52%. Compliance with all actions 1 to 6 (core bundle) was associated with an odds ratio (OR) of 0.44 [95% confidence interval (CI) = 0.24-0.80] in severe sepsis and 0.49 (95% CI = 0.25-0.95) in septic shock, for 28 days mortality. This corresponded to a number needed to treat of 6 patients to save one life.


CONCLUSIONS
Compliance with this core bundle was associated with a significant reduction in the 28 days mortality. Urgent action should be taken in order to ensure that early sepsis diagnosis is followed by full completion of this "core bundle" followed by activation of expertise help in severe sepsis.
Cardoso
Teresa
T
Unidade de Cuidados Intensivos Polivalente, Hospital Geral de Santo António, University of Porto, Largo Prof, Abel Salazar, 4099-001 Porto, Portugal. cardoso.tmc@gmail.com
Carneiro
António Henriques
AH
Ribeiro
Orquídea
O
Teixeira-Pinto
Armando
A
Costa-Pereira
Altamiro
A
D000328:Adult; D000368:Aged; D015331:Cohort Studies; D017714:Community-Acquired Infections / Q000401:mortality*; D016001:Confidence Intervals; D003422:Critical Care / Q000458:organization & administration*; D005260:Female; D017052:Hospital Mortality / Q000639:trends; D006801:Humans; D007362:Intensive Care Units / Q000592:standards; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011174:Portugal / Q000453:epidemiology; D011446:Prospective Studies; D018805:Sepsis / Q000401:mortality*; D012720:Severity of Illness Index; D013997:Time Factors
N Engl J Med. 2005 Sep 29;353(13):1332-41
16192478
BMJ. 2000 Oct 14;321(7266):950-3
11030691
N Engl J Med. 2008 Jan 10;358(2):111-24
18184957
Am J Respir Crit Care Med. 2003 Jul 1;168(1):77-84
12702548
Crit Care Med. 1985 Oct;13(10):818-29
3928249
Crit Care. 2005;9(6):653-4
16356261
Crit Care. 2005;9(6):R764-70
16356225
Chest. 1992 Jun;101(6):1644-55
1303622
N Engl J Med. 2003 Apr 17;348(16):1546-54
12700374
Crit Care Med. 2004 Mar;32(3):858-73
15090974
Crit Care Med. 2009 Feb;37(2):410-6
19114885
JAMA. 1993 Dec 22-29;270(24):2957-63
8254858
Crit Care Med. 2006 Apr;34(4):1025-32
16484890
Crit Care Med. 2003 Apr;31(4):1250-6
12682500
J Clin Epidemiol. 2002 May;55(5):525-30
12007557
Am J Emerg Med. 2006 Sep;24(5):553-9
16938593
J Intern Med. 2004 Oct;256(4):316-23
15367174
Crit Care Med. 2004 Nov;32(11 Suppl):S595-7
15542969
Crit Care Med. 2007 Apr;35(4):1105-12
17334251
Med J Aust. 2004 Oct 18;181(8):428-31
15487958
N Engl J Med. 2009 Mar 26;360(13):1283-97
19318384
Chest. 2006 Nov;130(5):1579-95
17099041
JAMA. 2008 May 21;299(19):2294-303
18492971
Mayo Clin Proc. 2002 Jun;77(6):542-51
12059124
Crit Care Med. 2008 Jan;36(1):296-327
18158437
Intensive Care Med. 1996 Jul;22(7):707-10
8844239
Lancet. 1996 Sep 21;348(9030):771-5
8813982
Eur J Trauma Emerg Surg. 2008 Dec;34(6):561-9
26816280